img

Global Obsessive-Compulsive Disorder Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Obsessive-Compulsive Disorder Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
Obsessive-Compulsive Disorder Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Obsessive-Compulsive Disorder Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Homecare are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Obsessive-Compulsive Disorder Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Obsessive-Compulsive Disorder Medicine key manufacturers include Sun pharmaceuticals industry Ltd., H.Lunderbeck A/S, Eli Lilly and company, Apotex Inc., Viatris Inc., Lannett, GlaxoSmithKline Plc., Alvogen and Pfizer Inc., etc. Sun pharmaceuticals industry Ltd., H.Lunderbeck A/S, Eli Lilly and company are top 3 players and held % sales share in total in 2022.
Obsessive-Compulsive Disorder Medicine can be divided into NMDA Receptor Blockers, Antipsychotics and Antidepressants,, etc. NMDA Receptor Blockers is the mainstream product in the market, accounting for % sales share globally in 2022.
Obsessive-Compulsive Disorder Medicine is widely used in various fields, such as Hospitals, Homecare, Clinics and Others, etc. Hospitals provides greatest supports to the Obsessive-Compulsive Disorder Medicine industry development. In 2022, global % sales of Obsessive-Compulsive Disorder Medicine went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Obsessive-Compulsive Disorder Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sun pharmaceuticals industry Ltd.
H.Lunderbeck A/S
Eli Lilly and company
Apotex Inc.
Viatris Inc.
Lannett
GlaxoSmithKline Plc.
Alvogen
Pfizer Inc.
Amneal Pharmaceuticals LLC.
Dr. Reddy's Laboratories Ltd.
Abbott
Par Pharmaceuticals
Sebela Pharmaceuticals
Mallinckrodt
Lupin
Segment by Type
NMDA Receptor Blockers
Antipsychotics
Antidepressants

Segment by Application


Hospitals
Homecare
Clinics
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Obsessive-Compulsive Disorder Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Obsessive-Compulsive Disorder Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Obsessive-Compulsive Disorder Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Obsessive-Compulsive Disorder Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Obsessive-Compulsive Disorder Medicine introduction, etc. Obsessive-Compulsive Disorder Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Obsessive-Compulsive Disorder Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Obsessive-Compulsive Disorder Medicine Market Overview
1.1 Obsessive-Compulsive Disorder Medicine Product Overview
1.2 Obsessive-Compulsive Disorder Medicine Market Segment by Type
1.2.1 NMDA Receptor Blockers
1.2.2 Antipsychotics
1.2.3 Antidepressants
1.3 Global Obsessive-Compulsive Disorder Medicine Market Size by Type
1.3.1 Global Obsessive-Compulsive Disorder Medicine Market Size Overview by Type (2024-2034)
1.3.2 Global Obsessive-Compulsive Disorder Medicine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Obsessive-Compulsive Disorder Medicine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Obsessive-Compulsive Disorder Medicine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Obsessive-Compulsive Disorder Medicine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Breakdown by Type (2024-2024)
2 Global Obsessive-Compulsive Disorder Medicine Market Competition by Company
2.1 Global Top Players by Obsessive-Compulsive Disorder Medicine Sales (2024-2024)
2.2 Global Top Players by Obsessive-Compulsive Disorder Medicine Revenue (2024-2024)
2.3 Global Top Players by Obsessive-Compulsive Disorder Medicine Price (2024-2024)
2.4 Global Top Manufacturers Obsessive-Compulsive Disorder Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Obsessive-Compulsive Disorder Medicine Market Competitive Situation and Trends
2.5.1 Obsessive-Compulsive Disorder Medicine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Obsessive-Compulsive Disorder Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Obsessive-Compulsive Disorder Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into Obsessive-Compulsive Disorder Medicine Market
2.8 Key Manufacturers Obsessive-Compulsive Disorder Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Obsessive-Compulsive Disorder Medicine Status and Outlook by Region
3.1 Global Obsessive-Compulsive Disorder Medicine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Obsessive-Compulsive Disorder Medicine Historic Market Size by Region
3.2.1 Global Obsessive-Compulsive Disorder Medicine Sales in Volume by Region (2024-2024)
3.2.2 Global Obsessive-Compulsive Disorder Medicine Sales in Value by Region (2024-2024)
3.2.3 Global Obsessive-Compulsive Disorder Medicine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Region
3.3.1 Global Obsessive-Compulsive Disorder Medicine Sales in Volume by Region (2024-2034)
3.3.2 Global Obsessive-Compulsive Disorder Medicine Sales in Value by Region (2024-2034)
3.3.3 Global Obsessive-Compulsive Disorder Medicine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Obsessive-Compulsive Disorder Medicine by Application
4.1 Obsessive-Compulsive Disorder Medicine Market Segment by Application
4.1.1 Hospitals
4.1.2 Homecare
4.1.3 Clinics
4.1.4 Others
4.2 Global Obsessive-Compulsive Disorder Medicine Market Size by Application
4.2.1 Global Obsessive-Compulsive Disorder Medicine Market Size Overview by Application (2024-2034)
4.2.2 Global Obsessive-Compulsive Disorder Medicine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Obsessive-Compulsive Disorder Medicine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Obsessive-Compulsive Disorder Medicine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Obsessive-Compulsive Disorder Medicine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Breakdown by Application (2024-2024)
5 North America Obsessive-Compulsive Disorder Medicine by Country
5.1 North America Obsessive-Compulsive Disorder Medicine Historic Market Size by Country
5.1.1 North America Obsessive-Compulsive Disorder Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2024)
5.1.3 North America Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2024)
5.2 North America Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Country
5.2.1 North America Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2034)
5.2.2 North America Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2034)
6 Europe Obsessive-Compulsive Disorder Medicine by Country
6.1 Europe Obsessive-Compulsive Disorder Medicine Historic Market Size by Country
6.1.1 Europe Obsessive-Compulsive Disorder Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2024)
6.1.3 Europe Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2024)
6.2 Europe Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Country
6.2.1 Europe Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2034)
6.2.2 Europe Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2034)
7 Asia-Pacific Obsessive-Compulsive Disorder Medicine by Region
7.1 Asia-Pacific Obsessive-Compulsive Disorder Medicine Historic Market Size by Region
7.1.1 Asia-Pacific Obsessive-Compulsive Disorder Medicine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales in Value by Region (2024-2034)
8 Latin America Obsessive-Compulsive Disorder Medicine by Country
8.1 Latin America Obsessive-Compulsive Disorder Medicine Historic Market Size by Country
8.1.1 Latin America Obsessive-Compulsive Disorder Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2024)
8.2 Latin America Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Country
8.2.1 Latin America Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2034)
9 Middle East and Africa Obsessive-Compulsive Disorder Medicine by Country
9.1 Middle East and Africa Obsessive-Compulsive Disorder Medicine Historic Market Size by Country
9.1.1 Middle East and Africa Obsessive-Compulsive Disorder Medicine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Obsessive-Compulsive Disorder Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sun pharmaceuticals industry Ltd.
10.1.1 Sun pharmaceuticals industry Ltd. Company Information
10.1.2 Sun pharmaceuticals industry Ltd. Introduction and Business Overview
10.1.3 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Products Offered
10.1.5 Sun pharmaceuticals industry Ltd. Recent Development
10.2 H.Lunderbeck A/S
10.2.1 H.Lunderbeck A/S Company Information
10.2.2 H.Lunderbeck A/S Introduction and Business Overview
10.2.3 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Products Offered
10.2.5 H.Lunderbeck A/S Recent Development
10.3 Eli Lilly and company
10.3.1 Eli Lilly and company Company Information
10.3.2 Eli Lilly and company Introduction and Business Overview
10.3.3 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Eli Lilly and company Obsessive-Compulsive Disorder Medicine Products Offered
10.3.5 Eli Lilly and company Recent Development
10.4 Apotex Inc.
10.4.1 Apotex Inc. Company Information
10.4.2 Apotex Inc. Introduction and Business Overview
10.4.3 Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Apotex Inc. Obsessive-Compulsive Disorder Medicine Products Offered
10.4.5 Apotex Inc. Recent Development
10.5 Viatris Inc.
10.5.1 Viatris Inc. Company Information
10.5.2 Viatris Inc. Introduction and Business Overview
10.5.3 Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Viatris Inc. Obsessive-Compulsive Disorder Medicine Products Offered
10.5.5 Viatris Inc. Recent Development
10.6 Lannett
10.6.1 Lannett Company Information
10.6.2 Lannett Introduction and Business Overview
10.6.3 Lannett Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Lannett Obsessive-Compulsive Disorder Medicine Products Offered
10.6.5 Lannett Recent Development
10.7 GlaxoSmithKline Plc.
10.7.1 GlaxoSmithKline Plc. Company Information
10.7.2 GlaxoSmithKline Plc. Introduction and Business Overview
10.7.3 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Products Offered
10.7.5 GlaxoSmithKline Plc. Recent Development
10.8 Alvogen
10.8.1 Alvogen Company Information
10.8.2 Alvogen Introduction and Business Overview
10.8.3 Alvogen Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Alvogen Obsessive-Compulsive Disorder Medicine Products Offered
10.8.5 Alvogen Recent Development
10.9 Pfizer Inc.
10.9.1 Pfizer Inc. Company Information
10.9.2 Pfizer Inc. Introduction and Business Overview
10.9.3 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Pfizer Inc. Obsessive-Compulsive Disorder Medicine Products Offered
10.9.5 Pfizer Inc. Recent Development
10.10 Amneal Pharmaceuticals LLC.
10.10.1 Amneal Pharmaceuticals LLC. Company Information
10.10.2 Amneal Pharmaceuticals LLC. Introduction and Business Overview
10.10.3 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Products Offered
10.10.5 Amneal Pharmaceuticals LLC. Recent Development
10.11 Dr. Reddy's Laboratories Ltd.
10.11.1 Dr. Reddy's Laboratories Ltd. Company Information
10.11.2 Dr. Reddy's Laboratories Ltd. Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Products Offered
10.11.5 Dr. Reddy's Laboratories Ltd. Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Abbott Obsessive-Compulsive Disorder Medicine Products Offered
10.12.5 Abbott Recent Development
10.13 Par Pharmaceuticals
10.13.1 Par Pharmaceuticals Company Information
10.13.2 Par Pharmaceuticals Introduction and Business Overview
10.13.3 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Products Offered
10.13.5 Par Pharmaceuticals Recent Development
10.14 Sebela Pharmaceuticals
10.14.1 Sebela Pharmaceuticals Company Information
10.14.2 Sebela Pharmaceuticals Introduction and Business Overview
10.14.3 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Products Offered
10.14.5 Sebela Pharmaceuticals Recent Development
10.15 Mallinckrodt
10.15.1 Mallinckrodt Company Information
10.15.2 Mallinckrodt Introduction and Business Overview
10.15.3 Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Mallinckrodt Obsessive-Compulsive Disorder Medicine Products Offered
10.15.5 Mallinckrodt Recent Development
10.16 Lupin
10.16.1 Lupin Company Information
10.16.2 Lupin Introduction and Business Overview
10.16.3 Lupin Obsessive-Compulsive Disorder Medicine Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Lupin Obsessive-Compulsive Disorder Medicine Products Offered
10.16.5 Lupin Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Obsessive-Compulsive Disorder Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Obsessive-Compulsive Disorder Medicine Industrial Chain Analysis
11.4 Obsessive-Compulsive Disorder Medicine Market Dynamics
11.4.1 Obsessive-Compulsive Disorder Medicine Industry Trends
11.4.2 Obsessive-Compulsive Disorder Medicine Market Drivers
11.4.3 Obsessive-Compulsive Disorder Medicine Market Challenges
11.4.4 Obsessive-Compulsive Disorder Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Obsessive-Compulsive Disorder Medicine Distributors
12.3 Obsessive-Compulsive Disorder Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of NMDA Receptor Blockers
Table 2. Major Company of Antipsychotics
Table 3. Major Company of Antidepressants
Table 4. Global Obsessive-Compulsive Disorder Medicine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (K Units)
Table 6. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US& Million)
Table 8. Global Obsessive-Compulsive Disorder Medicine Market Share in Value by Type (2024-2024)
Table 9. Global Obsessive-Compulsive Disorder Medicine Price by Type (2024-2024) & (USD/Unit)
Table 10. Global Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2034) & (K Units)
Table 11. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type (2024-2034)
Table 14. Global Obsessive-Compulsive Disorder Medicine Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (K Units)
Table 16. North America Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Obsessive-Compulsive Disorder Medicine Sales (K Units) by Type (2024-2024)
Table 18. Europe Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Obsessive-Compulsive Disorder Medicine Sales (K Units) by Type (2024-2024)
Table 22. Latin America Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Obsessive-Compulsive Disorder Medicine Sales by Company (2024-2024) & (K Units)
Table 26. Global Obsessive-Compulsive Disorder Medicine Sales Share by Company (2024-2024)
Table 27. Global Obsessive-Compulsive Disorder Medicine Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Obsessive-Compulsive Disorder Medicine Revenue Share by Company (2024-2024)
Table 29. Global Market Obsessive-Compulsive Disorder Medicine Price by Company (2024-2024) & (USD/Unit)
Table 30. Global Obsessive-Compulsive Disorder Medicine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Obsessive-Compulsive Disorder Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Obsessive-Compulsive Disorder Medicine as of 2022)
Table 33. Date of Key Manufacturers Enter into Obsessive-Compulsive Disorder Medicine Market
Table 34. Key Manufacturers Obsessive-Compulsive Disorder Medicine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Obsessive-Compulsive Disorder Medicine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2024) & (K Units)
Table 38. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Region (2024-2024)
Table 41. Global Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 42. Global Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2034) & (K Units)
Table 43. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Region (2024-2034)
Table 46. Global Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Obsessive-Compulsive Disorder Medicine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (K Units)
Table 49. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application (2024-2024)
Table 52. Global Obsessive-Compulsive Disorder Medicine Price by Application (2024-2024) & (USD/Unit)
Table 53. Global Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2034) & (K Units)
Table 54. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application (2024-2034)
Table 57. Global Obsessive-Compulsive Disorder Medicine Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) (K Units)
Table 59. North America Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) (K Units)
Table 61. Europe Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) (K Units)
Table 65. Latin America Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (K Units)
Table 69. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2024)
Table 72. North America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (K Units)
Table 73. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (K Units)
Table 77. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (K Units)
Table 81. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Country (2024-2034)
Table 108. Sun pharmaceuticals industry Ltd. Company Information
Table 109. Sun pharmaceuticals industry Ltd. Introduction and Business Overview
Table 110. Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 111. Sun pharmaceuticals industry Ltd. Obsessive-Compulsive Disorder Medicine Product
Table 112. Sun pharmaceuticals industry Ltd. Recent Development
Table 113. H.Lunderbeck A/S Company Information
Table 114. H.Lunderbeck A/S Introduction and Business Overview
Table 115. H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 116. H.Lunderbeck A/S Obsessive-Compulsive Disorder Medicine Product
Table 117. H.Lunderbeck A/S Recent Development
Table 118. Eli Lilly and company Company Information
Table 119. Eli Lilly and company Introduction and Business Overview
Table 120. Eli Lilly and company Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 121. Eli Lilly and company Obsessive-Compulsive Disorder Medicine Product
Table 122. Eli Lilly and company Recent Development
Table 123. Apotex Inc. Company Information
Table 124. Apotex Inc. Introduction and Business Overview
Table 125. Apotex Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 126. Apotex Inc. Obsessive-Compulsive Disorder Medicine Product
Table 127. Apotex Inc. Recent Development
Table 128. Viatris Inc. Company Information
Table 129. Viatris Inc. Introduction and Business Overview
Table 130. Viatris Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 131. Viatris Inc. Obsessive-Compulsive Disorder Medicine Product
Table 132. Viatris Inc. Recent Development
Table 133. Lannett Company Information
Table 134. Lannett Introduction and Business Overview
Table 135. Lannett Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 136. Lannett Obsessive-Compulsive Disorder Medicine Product
Table 137. Lannett Recent Development
Table 138. GlaxoSmithKline Plc. Company Information
Table 139. GlaxoSmithKline Plc. Introduction and Business Overview
Table 140. GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 141. GlaxoSmithKline Plc. Obsessive-Compulsive Disorder Medicine Product
Table 142. GlaxoSmithKline Plc. Recent Development
Table 143. Alvogen Company Information
Table 144. Alvogen Introduction and Business Overview
Table 145. Alvogen Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 146. Alvogen Obsessive-Compulsive Disorder Medicine Product
Table 147. Alvogen Recent Development
Table 148. Pfizer Inc. Company Information
Table 149. Pfizer Inc. Introduction and Business Overview
Table 150. Pfizer Inc. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 151. Pfizer Inc. Obsessive-Compulsive Disorder Medicine Product
Table 152. Pfizer Inc. Recent Development
Table 153. Amneal Pharmaceuticals LLC. Company Information
Table 154. Amneal Pharmaceuticals LLC. Introduction and Business Overview
Table 155. Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 156. Amneal Pharmaceuticals LLC. Obsessive-Compulsive Disorder Medicine Product
Table 157. Amneal Pharmaceuticals LLC. Recent Development
Table 158. Dr. Reddy's Laboratories Ltd. Company Information
Table 159. Dr. Reddy's Laboratories Ltd. Introduction and Business Overview
Table 160. Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 161. Dr. Reddy's Laboratories Ltd. Obsessive-Compulsive Disorder Medicine Product
Table 162. Dr. Reddy's Laboratories Ltd. Recent Development
Table 163. Abbott Company Information
Table 164. Abbott Introduction and Business Overview
Table 165. Abbott Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 166. Abbott Obsessive-Compulsive Disorder Medicine Product
Table 167. Abbott Recent Development
Table 168. Par Pharmaceuticals Company Information
Table 169. Par Pharmaceuticals Introduction and Business Overview
Table 170. Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 171. Par Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product
Table 172. Par Pharmaceuticals Recent Development
Table 173. Sebela Pharmaceuticals Company Information
Table 174. Sebela Pharmaceuticals Introduction and Business Overview
Table 175. Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 176. Sebela Pharmaceuticals Obsessive-Compulsive Disorder Medicine Product
Table 177. Sebela Pharmaceuticals Recent Development
Table 178. Mallinckrodt Company Information
Table 179. Mallinckrodt Introduction and Business Overview
Table 180. Mallinckrodt Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 181. Mallinckrodt Obsessive-Compulsive Disorder Medicine Product
Table 182. Mallinckrodt Recent Development
Table 183. Lupin Company Information
Table 184. Lupin Introduction and Business Overview
Table 185. Lupin Obsessive-Compulsive Disorder Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 186. Lupin Obsessive-Compulsive Disorder Medicine Product
Table 187. Lupin Recent Development
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Obsessive-Compulsive Disorder Medicine Market Trends
Table 191. Obsessive-Compulsive Disorder Medicine Market Drivers
Table 192. Obsessive-Compulsive Disorder Medicine Market Challenges
Table 193. Obsessive-Compulsive Disorder Medicine Market Restraints
Table 194. Obsessive-Compulsive Disorder Medicine Distributors List
Table 195. Obsessive-Compulsive Disorder Medicine Downstream Customers
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Obsessive-Compulsive Disorder Medicine Product Picture
Figure 2. Global Obsessive-Compulsive Disorder Medicine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Obsessive-Compulsive Disorder Medicine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Obsessive-Compulsive Disorder Medicine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of NMDA Receptor Blockers
Figure 6. Global NMDA Receptor Blockers Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Antipsychotics
Figure 8. Global Antipsychotics Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Antidepressants
Figure 10. Global Antidepressants Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Obsessive-Compulsive Disorder Medicine Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Type in 2022 & 2034
Figure 13. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type in 2022
Figure 14. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type in 2022
Figure 15. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Obsessive-Compulsive Disorder Medicine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Obsessive-Compulsive Disorder Medicine Revenue in 2022
Figure 25. Obsessive-Compulsive Disorder Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Homecare
Figure 29. Global Homecare Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Obsessive-Compulsive Disorder Medicine Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Obsessive-Compulsive Disorder Medicine Sales Market Share by Application in 2022 & 2034
Figure 36. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application in 2022
Figure 37. North America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application in 2022
Figure 38. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application in 2022
Figure 39. Europe Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application in 2022
Figure 42. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Obsessive-Compulsive Disorder Medicine Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Obsessive-Compulsive Disorder Medicine Manufacturing Cost Structure
Figure 47. Obsessive-Compulsive Disorder Medicine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries